Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age
Clinical trial NCT04210349 · COMPLETED
Trial details
- NCT number
- NCT04210349
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2020-12-01
- Enrollment
- 7106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.